Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Tectonic Therapeutic (TECX) Invested Capital (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Invested Capital data on record, last reported at $230.4 million in Q1 2026.

  • On a quarterly basis, Invested Capital fell 23.46% to $230.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $230.4 million, a 23.46% decrease, with the full-year FY2025 number at $251.3 million, up 78.53% from a year prior.
  • Invested Capital reached $230.4 million in Q1 2026 per TECX's latest filing, down from $251.3 million in the prior quarter.
  • Over the last five years, Invested Capital for TECX hit a ceiling of $301.0 million in Q1 2025 and a floor of -$99.6 million in Q1 2024.
  • A 5-year average of $105.6 million and a median of $140.8 million in 2024 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: plummeted 188.82% in 2023, then soared 402.32% in 2025.
  • Tracing TECX's Invested Capital over 5 years: stood at -$29.3 million in 2022, then tumbled by 188.82% to -$84.6 million in 2023, then soared by 266.33% to $140.8 million in 2024, then soared by 78.53% to $251.3 million in 2025, then dropped by 8.32% to $230.4 million in 2026.
  • Business Quant data shows Invested Capital for TECX at $230.4 million in Q1 2026, $251.3 million in Q4 2025, and $267.5 million in Q3 2025.